ポスト

SGLT2 inhibitors are a critical component of clinical practice guidelines for cardiovascular disease management. This Review discusses changes in kidney physiology after the SGLT2 inhibitor administration predicted to cause both hypokalemia & hyperkalemia https://t.co/PucubPD2Pf

メニューを開く

CJASN@CJASN

人気ポスト

もっと見る
Yahoo!リアルタイム検索アプリ